Iran, AI, and a $2.8B Lilly Shock
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Geopolitics Rattles Energy and Airlines
US military strikes against Iran shattered a fragile ceasefire today. Oil prices jumped on the news. Options traders piled into energy names — XOM and CVX drew heavy call activity. Both stocks carry minimal short interest below 1.5% of free float. Bears are not fighting the oil move. Airlines face the opposite pressure. DAL reports Q2 earnings Thursday. Rising fuel costs will be the central question on that call.
Eli Lilly Takes a $2.8B Hit
LLY disclosed a $2.8 billion Q2 IPR&D charge today. The write-down will hit GAAP and non-GAAP EPS by roughly $3.02 per share. That is a material dent for one of the market's most valued healthcare names. Analysts had recently lifted their target prices on medtech and pharma broadly — this charge complicates the picture for Lilly specifically.
OpenAI Fires Back in the AI Race
OpenAI launched GPT-Live today, taking direct aim at the AI voice assistant market. The move puts pressure on MSFT, which holds a deep partnership stake. CoreWeave — the AI cloud infrastructure name with 32.7% short interest — sits in the blast radius. Bears there are already elevated. More competitive pressure on AI economics will not help.
Canada: MDA Shorts Surge
MDA Space saw short interest spike 55% in a single day to 3.3 million shares. The stock dropped 5.6% on July 7. Availability remains wide at 1,316% of short interest. Shorts are easy to establish and appear to be pressing the position.
Earnings Countdown
LEVI and PEP report today. DAL follows Thursday. BAC opens the big bank season on July 14. Q2 earnings season is now underway.
Stocks in this article
How this article was generated
- Generated
- 8 Jul 2026, 20:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.